NewcelX Ltd. funding
NewcelX Ltd., a biotechnology company based in Kloten, Switzerland, filed a Form D with the SEC on August 24, 2026 and reported $2.9M raised. It filed 2 new offerings in this period, totaling $6.4M.
Amount raised$2.9M
Offering size$2.9M
Filed with the SECAugust 24, 2026
First saleJuly 3, 2026
IndustryBiotechnology
SecuritiesEquity, Options or warrants, Security to be acquired on exercise, Other
LocationKloten, Switzerland
FoundedMore than 5 years ago
Entity typeOther
Investors so far5
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Aug 24
All filings
| Filed | Raised | Offering | Securities |
|---|---|---|---|
| August 24, 2026 | $2.9M | $2.9M | Equity, Options or warrants, Security to be acquired on exercise, Other |
| May 13, 2026 | $3.4M | $3.4M | Equity, Options or warrants, Security to be acquired on exercise, Other |
Other health care rounds
Lisata Therapeutics, Inc.$352M · Oct 2BiotechnologyPrecision Neuroscience Corp$250M · Sep 28Other Health CareZai Lab Ltd$250M · Nov 9BiotechnologyAmerican Republic Insurance Co.$95M · Oct 22Health InsuranceBridge To Life Ltd.$82.5M · Oct 21Other Health CareAlpfa Medical, Inc.$80.3M · Sep 28Other Health CareBigHat Biosciences, Inc.$75.1M · Oct 26BiotechnologyTypewriter Therapeutics, Inc.$56.3M · Sep 21Biotechnology